Peter Hersey


Ontology type: schema:Person     


Person Info

NAME

Peter

SURNAME

Hersey

Publications in SciGraph latest 50 shown

  • 2021-01-19 Sex bias of females in survival from cancer and infections. Is X the answer? in BRITISH JOURNAL OF CANCER
  • 2020-01-29 Melanoma Vaccines in CUTANEOUS MELANOMA
  • 2018-11-19 Melanoma Vaccines in CUTANEOUS MELANOMA
  • 2018-08-24 SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling in NATURE COMMUNICATIONS
  • 2017-12-30 Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2017-05-03 Whole-genome landscapes of major melanoma subtypes in NATURE
  • 2015-09-25 Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases in MODERN PATHOLOGY
  • 2015-04-03 Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma in MODERN PATHOLOGY
  • 2014-11-06 Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-08-29 Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma in BMC CANCER
  • 2014-04-15 Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-08-04 Overcoming Resistance of Melanoma to Immunotherapy with Monoclonal Antibodies Against Checkpoints Inhibitors in RESISTANCE TO IMMUNOTHERAPEUTIC ANTIBODIES IN CANCER
  • 2013-06-17 Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma in ONCOGENE
  • 2013-06-06 Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3 in CELL DEATH & DISEASE
  • 2013-02-26 PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma in NATURE COMMUNICATIONS
  • 2012-06-28 Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress in CELL DEATH & DISEASE
  • 2011-11-13 Targeting Apoptotic Pathways in Melanoma in TARGETED THERAPEUTICS IN MELANOMA
  • 2011-05-27 P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation in BMC CANCER
  • 2011-03-21 Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress in ONCOGENE
  • 2010-09-02 Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS in CELL DEATH & DISEASE
  • 2010-06-01 TRAIL-induced apoptosis of human melanoma cells involves activation of caspase-4 in APOPTOSIS
  • 2010-03-30 A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy in MOLECULAR CANCER
  • 2010-03-19 Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells in CELL DEATH & DIFFERENTIATION
  • 2009-12-14 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2 in MOLECULAR CANCER
  • 2009-10-16 Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins in MODERN PATHOLOGY
  • 2009-07-14 Societal preference values for advanced melanoma health states in the United Kingdom and Australia in BRITISH JOURNAL OF CANCER
  • 2009-06-24 Treatment combinations targeting apoptosis to improve immunotherapy of melanoma in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2009-04-14 O6-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib in BRITISH JOURNAL OF CANCER
  • 2008-11-07 Involvement of endoplasmic reticulum stress in Docetaxel-induced JNK-dependent apoptosis of human melanoma in APOPTOSIS
  • 2008 Overcoming Resistance to Apoptosis in Cancer Therapy in PROGRAMMED CELL DEATH IN CANCER PROGRESSION AND THERAPY
  • 2007-12-21 Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2007-10-30 Temozolomide induces senescence but not apoptosis in human melanoma cells in BRITISH JOURNAL OF CANCER
  • 2007-03-26 Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma in MODERN PATHOLOGY
  • 2006-10-17 Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells in APOPTOSIS
  • 2005-06 Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma in INVESTIGATIONAL NEW DRUGS
  • 2005-04-15 Is Apaf-1 expression frequently abrogated in melanoma? in CELL DEATH & DIFFERENTIATION
  • 2005 Regulation of Trail Receptor Expression in Human Melanoma in DEATH RECEPTORS IN CANCER THERAPY
  • 2004-09-21 Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2004-03-29 Microarray expression profiling in melanoma reveals a BRAF mutation signature in ONCOGENE
  • 2003-11-05 Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2003-05-15 Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria in ONCOGENE
  • 2001-11-01 How melanoma cells evade trail-induced apoptosis in NATURE REVIEWS CANCER
  • 2001 Utility of Tests for Circulating Melanoma Cells in Identifying Patients Who Develop Recurrent Melanoma in MINIMAL RESIDUAL DISEASE IN MELANOMA
  • 1998-02 The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia in BRITISH JOURNAL OF CANCER
  • 1997-02-01 Contrasting effects of T cell growth factors on T cell responses to melanoma in vitro in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 1997 Naevi and Solar Keratoses as Risk Factors for Melanoma in Australia in SKIN CANCER AND UV RADIATION
  • 1994-11 T cell recognition of melanoma antigens in association with HLA-A1 on allogeneic melanoma cells in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 1994-03 Melanoma Vaccines in DRUGS
  • 1992-03 Active immunotherapy with viral lysates of micrometastases following surgical removal of high risk melanoma in WORLD JOURNAL OF SURGERY
  • 1989-06 Potentiation of interleukin-2 production and its binding by monoclonal antibodies to the gangliosides GD3 and GD2 in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • Affiliations

  • University of Sydney (current)
  • University of Brescia
  • University of Pittsburgh Cancer Institute
  • University of Warwick
  • Macquarie University
  • Tufts Medical Center
  • Sir Charles Gairdner Hospital
  • Amgen (United States)
  • Princess Alexandra Hospital
  • Peter MacCallum Cancer Centre
  • Dana-Farber Cancer Institute
  • The Alfred Hospital
  • University of Oxford
  • New York University
  • Mater Misericordiae Hospital
  • University of Arizona
  • Angeles Clinic and Research Institute
  • Royal Adelaide Hospital
  • Princess Margaret Cancer Centre
  • Erasmus MC
  • Melanoma Institute Australia
  • Cancer Research UK Manchester Institute
  • Charité - University Medicine Berlin
  • University Hospital of Zurich
  • Mater Private Hospital
  • National and Kapodistrian University of Athens
  • John Radcliffe Hospital
  • University of Alabama at Birmingham
  • Centenary Institute of Cancer Medicine and Cell Biology
  • Westmead Institute for Medical Research
  • Churchill Hospital
  • Institut Gustave Roussy
  • Bayer (United States)
  • Kiel University
  • University of Colorado Cancer Center
  • Sydney Hospital
  • Rechts der Isar Hospital
  • University of Newcastle Australia
  • Universitätsklinikum Tübingen
  • John Hunter Hospital
  • The University of Texas MD Anderson Cancer Center
  • Royal Marsden Hospital
  • National Health Service
  • Medical University of Vienna
  • Moffitt Cancer Center
  • Calvary Mater Newcastle Hospital
  • AstraZeneca (United Kingdom)
  • University Medical Centre Mannheim
  • Austin Health
  • National Measurement Laboratory
  • St. Luke's Hospital
  • Johannes Gutenberg University of Mainz
  • Royal Prince Alfred Hospital
  • Oncology Specialists
  • Cancer Research UK
  • University of Pittsburgh
  • Goethe University Frankfurt
  • Royal North Shore Hospital
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.1013.3", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7637.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.478063.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7372.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1004.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.67033.31", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.3521.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417886.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412744.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1055.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1623.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4991.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.137628.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.460774.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.134563.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.488730.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416075.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415224.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5645.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419690.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.482185.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6363.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412004.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416562.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5216.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8348.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.265892.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.248902.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.452919.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415719.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419670.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9764.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.499234.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416790.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15474.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.266842.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411544.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414724.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.424926.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.451052.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.22937.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.468198.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413265.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417815.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411778.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410678.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.496759.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416480.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5802.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413249.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.477670.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.11485.39", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.21925.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7839.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412703.3", 
            "type": "Organization"
          }
        ], 
        "familyName": "Hersey", 
        "givenName": "Peter", 
        "id": "sg:person.01073667716.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-11-24T21:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/person/person_662.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01073667716.42'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01073667716.42'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01073667716.42'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01073667716.42'


     

    This table displays all metadata directly associated to this object as RDF triples.

    130 TRIPLES      10 PREDICATES      68 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01073667716.42 schema:affiliation N753604780c264f019de767d2af246a00
    2 grid-institutes:grid.1004.5
    3 grid-institutes:grid.1055.1
    4 grid-institutes:grid.11485.39
    5 grid-institutes:grid.134563.6
    6 grid-institutes:grid.137628.9
    7 grid-institutes:grid.14925.3b
    8 grid-institutes:grid.15474.33
    9 grid-institutes:grid.1623.6
    10 grid-institutes:grid.21925.3d
    11 grid-institutes:grid.22937.3d
    12 grid-institutes:grid.240145.6
    13 grid-institutes:grid.248902.5
    14 grid-institutes:grid.265892.2
    15 grid-institutes:grid.266842.c
    16 grid-institutes:grid.3521.5
    17 grid-institutes:grid.410678.c
    18 grid-institutes:grid.411544.1
    19 grid-institutes:grid.411778.c
    20 grid-institutes:grid.412004.3
    21 grid-institutes:grid.412703.3
    22 grid-institutes:grid.412744.0
    23 grid-institutes:grid.413249.9
    24 grid-institutes:grid.413265.7
    25 grid-institutes:grid.414724.0
    26 grid-institutes:grid.415224.4
    27 grid-institutes:grid.415719.f
    28 grid-institutes:grid.416075.1
    29 grid-institutes:grid.416480.f
    30 grid-institutes:grid.416562.2
    31 grid-institutes:grid.416790.d
    32 grid-institutes:grid.417815.e
    33 grid-institutes:grid.417886.4
    34 grid-institutes:grid.419670.d
    35 grid-institutes:grid.419690.3
    36 grid-institutes:grid.424926.f
    37 grid-institutes:grid.451052.7
    38 grid-institutes:grid.452919.2
    39 grid-institutes:grid.460774.6
    40 grid-institutes:grid.468198.a
    41 grid-institutes:grid.477670.5
    42 grid-institutes:grid.478063.e
    43 grid-institutes:grid.482185.2
    44 grid-institutes:grid.488730.0
    45 grid-institutes:grid.496759.0
    46 grid-institutes:grid.4991.5
    47 grid-institutes:grid.499234.1
    48 grid-institutes:grid.5216.0
    49 grid-institutes:grid.5645.2
    50 grid-institutes:grid.5802.f
    51 grid-institutes:grid.6363.0
    52 grid-institutes:grid.65499.37
    53 grid-institutes:grid.67033.31
    54 grid-institutes:grid.7372.1
    55 grid-institutes:grid.7637.5
    56 grid-institutes:grid.7839.5
    57 grid-institutes:grid.8348.7
    58 grid-institutes:grid.9764.c
    59 schema:familyName Hersey
    60 schema:givenName Peter
    61 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42
    62 schema:sdDatePublished 2022-11-24T21:36
    63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    64 schema:sdPublisher N2fde116dd65f481eb36eebc692fc1173
    65 sgo:license sg:explorer/license/
    66 sgo:sdDataset persons
    67 rdf:type schema:Person
    68 N2fde116dd65f481eb36eebc692fc1173 schema:name Springer Nature - SN SciGraph project
    69 rdf:type schema:Organization
    70 N753604780c264f019de767d2af246a00 schema:affiliation grid-institutes:grid.1013.3
    71 sgo:isCurrent true
    72 rdf:type schema:OrganizationRole
    73 grid-institutes:grid.1004.5 schema:Organization
    74 grid-institutes:grid.1013.3 schema:Organization
    75 grid-institutes:grid.1055.1 schema:Organization
    76 grid-institutes:grid.11485.39 schema:Organization
    77 grid-institutes:grid.134563.6 schema:Organization
    78 grid-institutes:grid.137628.9 schema:Organization
    79 grid-institutes:grid.14925.3b schema:Organization
    80 grid-institutes:grid.15474.33 schema:Organization
    81 grid-institutes:grid.1623.6 schema:Organization
    82 grid-institutes:grid.21925.3d schema:Organization
    83 grid-institutes:grid.22937.3d schema:Organization
    84 grid-institutes:grid.240145.6 schema:Organization
    85 grid-institutes:grid.248902.5 schema:Organization
    86 grid-institutes:grid.265892.2 schema:Organization
    87 grid-institutes:grid.266842.c schema:Organization
    88 grid-institutes:grid.3521.5 schema:Organization
    89 grid-institutes:grid.410678.c schema:Organization
    90 grid-institutes:grid.411544.1 schema:Organization
    91 grid-institutes:grid.411778.c schema:Organization
    92 grid-institutes:grid.412004.3 schema:Organization
    93 grid-institutes:grid.412703.3 schema:Organization
    94 grid-institutes:grid.412744.0 schema:Organization
    95 grid-institutes:grid.413249.9 schema:Organization
    96 grid-institutes:grid.413265.7 schema:Organization
    97 grid-institutes:grid.414724.0 schema:Organization
    98 grid-institutes:grid.415224.4 schema:Organization
    99 grid-institutes:grid.415719.f schema:Organization
    100 grid-institutes:grid.416075.1 schema:Organization
    101 grid-institutes:grid.416480.f schema:Organization
    102 grid-institutes:grid.416562.2 schema:Organization
    103 grid-institutes:grid.416790.d schema:Organization
    104 grid-institutes:grid.417815.e schema:Organization
    105 grid-institutes:grid.417886.4 schema:Organization
    106 grid-institutes:grid.419670.d schema:Organization
    107 grid-institutes:grid.419690.3 schema:Organization
    108 grid-institutes:grid.424926.f schema:Organization
    109 grid-institutes:grid.451052.7 schema:Organization
    110 grid-institutes:grid.452919.2 schema:Organization
    111 grid-institutes:grid.460774.6 schema:Organization
    112 grid-institutes:grid.468198.a schema:Organization
    113 grid-institutes:grid.477670.5 schema:Organization
    114 grid-institutes:grid.478063.e schema:Organization
    115 grid-institutes:grid.482185.2 schema:Organization
    116 grid-institutes:grid.488730.0 schema:Organization
    117 grid-institutes:grid.496759.0 schema:Organization
    118 grid-institutes:grid.4991.5 schema:Organization
    119 grid-institutes:grid.499234.1 schema:Organization
    120 grid-institutes:grid.5216.0 schema:Organization
    121 grid-institutes:grid.5645.2 schema:Organization
    122 grid-institutes:grid.5802.f schema:Organization
    123 grid-institutes:grid.6363.0 schema:Organization
    124 grid-institutes:grid.65499.37 schema:Organization
    125 grid-institutes:grid.67033.31 schema:Organization
    126 grid-institutes:grid.7372.1 schema:Organization
    127 grid-institutes:grid.7637.5 schema:Organization
    128 grid-institutes:grid.7839.5 schema:Organization
    129 grid-institutes:grid.8348.7 schema:Organization
    130 grid-institutes:grid.9764.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...